Synergystic antitumor effect of polyphenolic components of water soluble derivative of propolis against Ehrlich ascites tumour

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 4, 2005, Pages 694-700

  Oršolić, Nada ^a   Kosalec, Ivan ^b   Bašić, Ivan ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Ehrlich ascites tumour (EAT) tumor; Polyphenolic compound; Propolis

Indexed keywords

CAFFEIC ACID; CHRYSIN; CONAP; NARINGENIN; POLYPHENOL DERIVATIVE; PROPOLIS; QUERCETIN; ANTINEOPLASTIC AGENT; CAFFEIC ACID DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONOID; PHENOL DERIVATIVE; POLYPHENOLS;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CELL COUNT; CELL KINETICS; CELL PROLIFERATION; CELL SPREADING; CONTROLLED STUDY; DRUG FORMULATION; DRUG POTENTIATION; DRUG SOLUBILITY; DRUG SYNTHESIS; EHRLICH ASCITES TUMOR; INHIBITION KINETICS; MACROPHAGE; MALE; MOUSE; NONHUMAN; POLYMORPHONUCLEAR CELL; ANIMAL; ASCITES FLUID; CHEMISTRY; CYTOLOGY; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PERITONEAL CAVITY;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; ASCITIC FLUID; CAFFEIC ACIDS; CARCINOMA, EHRLICH TUMOR; DRUG SYNERGISM; FLAVANONES; FLAVONOIDS; INJECTIONS, INTRAPERITONEAL; MACROPHAGES; MICE; PERITONEAL CAVITY; PHENOLS; PROPOLIS; QUERCETIN;

EID: 21144450083     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.694     Document Type: Article

References (45)

1. Ghisalberti E., Bee World, 60, 59-84 (1979).
2. Walker P., Crane E., Apidologie, 18, 327-334 (1987).
3. Bankova V., Christov R., Stoev G., Popov S., J. Chromatogr., 607, 150-153 (1992).
4. Bankova V., Christov R., Popov S., Z. Naturforsch. C, 49, 6-10 (1994).
5. Marcucci M. C., Apidologie, 26, 83-99 (1995).
6. Matsuno T., Matsumoto Y., Saito M., Morikawa J., Z. Naturforsch C, 52, 702-704 (1997).
7. Kimoto T., Aga M., Hino K., Koya-Miyata S., Yamamoto Y., Micallef M. J., Hanaya T., Arai S., Ikeda M., Kurimoto M., Anticancer Res., 21, 221-228 (2001).
8. Akao Y., Maruyama H., Matsumoto K., Ohguchi K., Nishizawa K., Sakamoto T., Araki Y., Mishima S., Nozawa Y., Biol. Pharm. Bull., 26, 1057-1059 (2003).
9. Amoros M., Sauvager F., Girre L., Cormier M., Apidologie, 23, 231-245 (1992).
10. Debiaggi M., Tateo F., Pagani L., Luini M., Romero E., Microbiologica, 13, 207-213 (1990).
11. Amoros M., Lurton E., Boustie J., Girre L., Sauvager F., Cormier M., J. Nat. Prod., 57, 644-647 (1994).
12. Brumfitt W., Hamillton-Miller J. T. M., Franklin I., Microbios, 62, 19-22 (1990).
13. Grange J. M., Davey R. W., J. R. Soc. Med., 83, 159-160 (1990).
14. Focht J., Hansen S. H., Nielsen J. V., Arzneim-Forsch/Drug Res., 43, 921-924 (1993).
15. La Torre A., Guccione M., Imbroglini G., Apicoltura, 6, 169-177 (1990).
16. Lori G. A., Ind. Apic., 1, 38-43 (1990).
17. Scheller S., Krol W., Swiacik J., Owczarek S., Gabrys J., Shani J., Z. Naturforsch., 44c, 1063-1065 (1989).
18. So F. V., Guthrie N., Chambers A. F., Moussa M., Carroll K. K., Nutr. Cancer, 26, 167-181 (1996).
19. Hayashi A., Gillen A. C., Lott J. R., Altern. Med. Rev., 5, 546-552 (2000).
20. Chiao C., Carothers A. M., Grunberger D., Solomon G., Preston A. G., Barrett C. J., Cancer Res., 55, 3576-3583 (1995).
21. Rao C. V., Desai D., Rivenson A., Simi B., Amin S., Reddy S. B., Cancer Res., 55, 2310-2315 (1995).
22. Oršolić N., Bašić I., J. Ethnopharmacol., 84, 265-273 (2003).
23. Bašić I., Oršolić N., Tadić Z., Macedo Fereire Alcici N., Brbot Šaranović A., Bendelja K., Kjsnik B., Rabatić S., "17th International Cancer Congress," ed. by Moraes M., Brentani R., Bevilaqua R., Rio de Jeneiro, Brazil, 1988, pp. 63-75.
24. Sun Z. J., Pan C. E., Liu H. S., Wang G. J., World J. Gastroenterol., 8, 79-81 (2002).
25. Manolova N., Maximova V., Manolova Z., Stoilova I., Korczak E., Denis A., Acta Microbiol. Bulg., 21, 76-81 (1987).
26. Dimov V., Ivanovska N., Bankova V., Popov S., Vaccine, 10, 817-823 (1992).
27. Dimov V., Ivanovska N., Manolova N., Bankova V., Nikolov N., Popov S., Apidologie, 22, 155-162 (1991).
28. Havsteen B., Biochem. Pharmacol., 32, 1141-1148 (1983).
29. Wleklik M., Zahorska R., Luczak V., Acta Microbiol. Pol., 32, 1141-1148 (1997).
30. Oršolić N., Bašić I., Mellifera, 3, 56-64 (2003).
31. Moreno M., Isla M., Sampietro A., Vattuone M., J. Ethnopharmacol., 71, 109-114 (2000).
32. Nikolov N., Marekov N., Bankova V., Popov S., Ignatova R., Vladimirova I., Bul. Pat. Appl. 79903/28, 05, (1987).
33. Bergman R. A., Afifi A. K., Heidger P. M., "Histology," Saunders Publishing, Philadelphia, Pa, 1995.
34. Fecchio D., Sirois P., Russo M., Jancar S., Inflammation, 14, 125-132 (1990).
35. Rabinovitch M., Manejias R. E., Russo M., Abbey E. E., Cell Immunol., 29, 86-95 (1977).
36. Rabinovitch M., DeStefano M. J., Exp. Cell Res., 77, 323-334 (1973).
37. Plowman J., Dykes D. J., Hollingshead M., Simpson-Herren L., Alley M. C., "Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval," ed. by Teicher B., Humana, Totowa, NJ, 1995, p. 101.
38. Freire B. F. A., "O Neutrófilo: Morfologia, Cinética e Função," Botucatu: Universidade Estadual Paulista, Faculdade de Medicina, Sao Paulo, 1994, p. 46 [Monografia].
39. Sezzi M. L., Bellelli L., Nista A., Oncology, 26, 529-539 (1972).
40. Oršolić N., Šver L., Terzić S., Tadić Z., Bašić I., Nutr. Cancer, 47, 156-163 (2003).
41. Oršolić N., Horvat Knežević A., Šver L., Terzić S., Bašić I., J. Ethnopharmacol., 94, 307-315 (2004).
42. Oršolić N., Bendelja K., Brbot-S̈aranović A., Bašić I., Period Biol., 106, 367-372 (2004).
43. Bellelli L., Sezzi M. L., Oncology, 33, 215-218 (1976).
44. Kimoto T., Arai S., Kohguchi M., Aga M., Nomura Y., Micallef M. J., Kurimoto M., Mito K., Cancer Detect. Prev., 22, 506-515 (1998).
45. Csokay B., Prajda N., Weber G., Olah E., Life Sci., 60, 2157-2163 (1997).